Navigation Links
URAC Names Sensei for Weight Loss as a Finalist in First-Ever Best Practices in Consumer Empowerment and Protection Awards
Date:12/5/2007

Sensei to Showcase Its Winning Program at URAC Conference and Exhibit,

March 25-26, 2008

WASHINGTON, Dec. 5 /PRNewswire/ -- On November 29, URAC announced that a distinguished panel of judges has selected the finalists for its inaugural Best Practices in Consumer Empowerment and Protection Awards competition. The nation-wide competition attracted entries detailing innovative and proven programs that are enhancing patient safety and giving consumers more control over their health care. Winners represent health plans, pharmacy benefit management organizations, health care management companies and health information technology companies. Sensei for Weight Loss,(TM) Sensei, Inc., a Humana joint venture, was among the finalists eligible to receive further distinction as an award winner, to be announced in March, 2008.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071205/NYW096LOGO )

"The fact that Sensei for Weight Loss -- launched a mere two weeks ago, has been named a Finalist by URAC among such a distinguished list of nominees has been a tremendous validation for us," said Dr. Robert Schwarzberg, president and CEO of Sensei, a pioneer in mobile and Web-based wellness solutions based in Boca Raton FL.

Sensei for Weight Loss provides a next-generation approach to health and weight management with a Web 2.0 Internet experience synchronized with your handset, turning a consumer's mobile phone into their own "personal digital coach (PDC). "For employees facing rising health care costs and declining productivity due to weight-management problems, as well as for consumers in search of long-lasting results, Sensei for Weight Loss represents a practical and sustainable solution," said Dr. Schwarzberg.

Entries were judged by a distinguished panel of judges, chaired by epidemiologist Thomas W. Wilson, Ph.D., DrPH, Trajectory H
'/>"/>

SOURCE Sensei, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. ResMed Names Kieran Gallahue as Chief Executive Officer, Effective January 1, 2008.
2. Mediware Names Thomas K. Mann Chief Executive Officer
3. Cleveland-based Health Care Tech Company Within3 Names New CEO
4. STERIS Corporation Board of Directors Names Walter M. Rosebrough Jr. President and Chief Executive Officer
5. Patient Safety Authority Board of Directors Names Infection Advisory Panel
6. Hooper Holmes Names Chris Behling President of Health & Wellness Division
7. MDMA Names New Director of Federal Affairs
8. Milestone Scientific Names Robert Presutti New Vice President of Sales and Marketing
9. Acuo Technologies(R) Names Mike Dolan Vice President of Sales
10. MAKO Surgical Corp. Names Frederic H. Moll, M.D. to Board of Directors
11. Arthur M. Blank Family Foundation Names Susan Bertonaschi Program Officer, Better Beginnings

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)... , The European Association of Urology (EAU) and ...he fight against prostate cancer, have entered int...-term commitment to increase and improve,patient ...eases., Professor Per-Anders Abrahamsson, Secret...U affiliated partnership, Europa Uomo will gain ac...
(Date:11/30/2009)... CHICAGONovember 30, 2009A pet owner knows the en... especially in troubled times. Most pets are consi...eable companions. A growing body of research now d...ld development, elderly care, mental illness, phys...ry, and the rehabilitation of incarcerated youth a...
(Date:11/30/2009)... The University of Navarra Hospital has launched ... efficacy of an immunotherapy treatment. This appr...ines produced from healthy and tumour cells from t...lioblastomas, one of the most aggressive and frequ...ered to participating patients combined with the s...
(Date:11/30/2009)... Author of "My Two-Y...r raising children who love to eat everything. , ...-- Do you have a picky eater in your house? Do yo...altime? Three new short online videos – one...ners, and the third on answers for real-life paren...
(Date:11/30/2009)...Like a pothole that worsens over time, so do knees...ONDAY, Nov. 30 (HealthDay News) -- If you,re a mid...tball court or hockey rink, take note: A new study...ost the risk of internal knee damage that could le...e injuries occurred in middle-age people who showe...
Breaking Medicine News(10 mins):Health News:The therapeutic benefits of the human-animal bond 2Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 2Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 3Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 4Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 5Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 6Health News:New Videos Help Parents of Picky Eaters 2Health News:New Videos Help Parents of Picky Eaters 3Health News:Lots of Exercise in Midlife May Lead to Osteoarthritis 2Health News:Lots of Exercise in Midlife May Lead to Osteoarthritis 3
...mirror LLC, a Philadelphia-based company offering ...DNA testing, is announcing the launch of their inn... affordable, easy-to-use product, with its user-fr...l HIV disease progression. HIVmirror(TM) i...
...earth endures, seedtime and harvest, cold and heat...e." - (Genesis 8:22, The Bible ). ...metime now. Needless to say, we, the people, of th...g the environmental crisis began way back in the t...
...enter for Consumer Freedom (CCF) welcomed a new st...tric & Adolescent Medicine, which will contribute ... the supposed link between television food adverti...that "children do not currently see more food ads ...
...udies have already revealed that stress boosts the...ers disease, a new study on mice has now shown th...ress-induced increases. The study, reported...first studies to elaborate the basic biomolecular ...
...ted wheat germ extract inhibits estrogen positive ...than the world's best selling cancer drug, Tamoxi...kend at the 2007 meeting of the American Society o...cal trials. In the current study, Andras Telekes, ...
...ound that tumor cell activity in women differs acc...east cancer in younger women. Breast canc... to treatment in women under 50 as compared to old...searchers led by Carey Anders at the Duke Institut...
Other Medicine News:Health News:HIVmirror, LLC Launching Breakthrough Genetic Product for HIV Positive Consumer 2Health News:World Environment Day (International Polar Year) 2Health News:World Environment Day (International Polar Year) 3Health News:World Environment Day (International Polar Year) 4Health News:New Studies: Commercials Aren't Making Kids Fat 2Health News:Stress Protein Inactivation Cuts Alzheimer's Peptide in Mice 2Health News:Wheat Germ Extract Inhibits Breast Cancer in Study 2
(Date:11/30/2009)... , , INDIANAPOLIS, Nov. 30 /PRNew...tration (FDA) has approved Cymbalta® (duloxet...zed anxiety disorder (GAD) in adults, Eli Lilly an...ince generalized anxiety disorder can be a chronic...atients find a treatment option that is effective ...
(Date:11/30/2009)... , , THOUSAND OAKS, Calif., Nov. 30 /PR... today announced that it will present updated long...omiplostim) in adult chronic immune (idiopathic) t... will present the first Nplate study in a pediatri...tic syndromes (MDS) at the 2009 American Society o...
(Date:11/29/2009)... , , CHICAGO, Nov. 30 Rad...is from a remote location with the use of a handhe...ftware, according to a study presented today at th...rth America (RSNA). ,, "The goal is to improve...ell as to improve communications among different c...
Breaking Medicine Technology:FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 2FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 3FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 4FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 5Amgen Highlights Data to be Presented at ASH 2Amgen Highlights Data to be Presented at ASH 3Amgen Highlights Data to be Presented at ASH 4Amgen Highlights Data to be Presented at ASH 5Amgen Highlights Data to be Presented at ASH 6Amgen Highlights Data to be Presented at ASH 7Amgen Highlights Data to be Presented at ASH 8Amgen Highlights Data to be Presented at ASH 9Amgen Highlights Data to be Presented at ASH 10Amgen Highlights Data to be Presented at ASH 11Smart Phones Allow Quick Diagnosis of Acute Appendicitis 2Smart Phones Allow Quick Diagnosis of Acute Appendicitis 3LG Electronics Introduces New Flat Panel HDTVs Designed Specifically for Long Term Care Facilities 53486 1LG Electronics Introduces New Flat Panel HDTVs Designed Specifically for Long Term Care Facilities 53486 2LG Electronics Introduces New Flat Panel HDTVs Designed Specifically for Long Term Care Facilities 53486 3LG Electronics Introduces New Flat Panel HDTVs Designed Specifically for Long Term Care Facilities 53486 4SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS 13331 1SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS 13331 2SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS 13331 3SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS 13331 4SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS 13331 5PDL BioPharma Elects Barry Selick to Its Board of Directors 53479 1PDL BioPharma Elects Barry Selick to Its Board of Directors 53479 2
..., Fla. , May 29 GlaxoSmithKline [NYSE: GSK] and ...ted States Food and Drug Administration,s (FDA) On...o three that the ARZERRA(TM) (ofatumumab) data are... patients with chronic lymphocytic leukemia (CLL) ...mtuzumab. Ofatumumab is an investigational treatme...
...VILLE, Pa., May 29 Wyeth Pharmaceuticals, a divis...minary data from two ongoing studies, one evaluati...umab (Herceptin(R), Roche) in HER-2 positive (ErbB...nvestigating neratinib safety and efficacy when gi...b) in patients with HER-2 dependent solid tumors. ...
Other Medicine Technology:FDA Advisory Panel Makes Favorable Recommendation for GlaxoSmithKline and Genmab's ARZERRA(TM) (ofatumumab) 2FDA Advisory Panel Makes Favorable Recommendation for GlaxoSmithKline and Genmab's ARZERRA(TM) (ofatumumab) 3FDA Advisory Panel Makes Favorable Recommendation for GlaxoSmithKline and Genmab's ARZERRA(TM) (ofatumumab) 4FDA Advisory Panel Makes Favorable Recommendation for GlaxoSmithKline and Genmab's ARZERRA(TM) (ofatumumab) 5New Preliminary Data from Two Studies Show Clinical Activity of Neratinib in Combination with Trastuzumab and in Combination with Paclitaxel in Advanced HER-2 Positive Breast Cancer 2New Preliminary Data from Two Studies Show Clinical Activity of Neratinib in Combination with Trastuzumab and in Combination with Paclitaxel in Advanced HER-2 Positive Breast Cancer 3New Preliminary Data from Two Studies Show Clinical Activity of Neratinib in Combination with Trastuzumab and in Combination with Paclitaxel in Advanced HER-2 Positive Breast Cancer 4New Preliminary Data from Two Studies Show Clinical Activity of Neratinib in Combination with Trastuzumab and in Combination with Paclitaxel in Advanced HER-2 Positive Breast Cancer 5
7121B Sony Medical Monitor
...ompletely new and revolutionary lens system. The u... size without distortion. The 115 field of view su...tion of the telescope. Beyond that a new quick loc... is introduced. It is the combination of outstandi...
...e the surgeon with an optimal work area and reduce...t and retinal surgery. Perfect Pupil Injectable is...pils which allows expansion of the pupil to 8mm co...gery, and allows the pupil to return to its normal...
Defiant 95% Bag Filter
Medicine Products: